Identification of new therapeutic leads for triple negative breast cancer subtypes

被引：0
|
作者：
Robles, A. J. [1 ]
Du, L. [3 ]
Cai, S. [3 ]
Cichewicz, R. H. [3 ]
Mooberry, S. L. [1 ,2 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA
[3] Univ Oklahoma, Inst Nat Prod Applicat & Res Technol, Nat Prod Discovery Grp, Norman, OK 73019 USA
来源：
PLANTA MEDICA | 2015年 / 81卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
PH4
引用
收藏
页码：890 / 890
页数：1
相关论文
共 50 条
  • [21] Therapeutic targets in triple negative breast cancer
    O'Toole, Sandra A.
    Beith, Jane M.
    Millar, Ewan K. A.
    West, Richard
    McLean, Anna
    Cazet, Aurelie
    Swarbrick, Alexander
    Oakes, Samantha R.
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (06) : 530 - 542
  • [22] Identification of lncRNAs as potential novel therapeutic targets in triple negative breast cancer
    O'Malley, Megan
    Rana, Zohaib
    Sarkar, Debina
    Chia, Jolyn
    Diermeier, Sarah
    CANCER RESEARCH, 2023, 83 (07)
  • [23] Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
    Gul, Samina
    Pang, Jianyu
    Yuan, Hongjun
    Chen, Yongzhi
    Yu, Qian
    Wang, Hui
    Tang, Wenru
    SCIENTIFIC DATA, 2023, 10 (01)
  • [24] Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer
    Li, Yan
    Yang, Shengjie
    Qi, Lu
    Li, Yinjuan
    Wang, Xinghe
    ADVANCES IN THERAPY, 2024, 41 (04) : 1621 - 1636
  • [25] Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
    Samina Gul
    Jianyu Pang
    Hongjun Yuan
    Yongzhi Chen
    Qian yu
    Hui Wang
    Wenru Tang
    Scientific Data, 10
  • [26] Identification of a Group of Therapeutic Targets and Prognostic Biomarker for Triple Negative Breast Cancer
    Yan Li
    Shengjie Yang
    Lu Qi
    Yinjuan Li
    Xinghe Wang
    Advances in Therapy, 2024, 41 : 1621 - 1636
  • [27] Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
    Ding, Ran
    Wang, Yuhan
    Fan, Jinyan
    Tian, Ziyue
    Wang, Shuang
    Qin, Xiujuan
    Su, Wei
    Wang, Yanbo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer
    Li, Shanqi
    Qian, Yuzhou
    Xie, Wanchen
    Li, Xinyu
    Wei, Jiaying
    Wang, Long
    Ren, Guosheng
    Yin, Xuedong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (03)
  • [29] Histologic Correlates of Molecular Subtypes of Triple Negative Breast Cancer
    Archambault-Marsan, Alexandre
    Wong, Jahg
    Al Shoukari, Ayman
    Lando, Leonardo
    Batardiere, Maelle
    Trinh, Vincent Quoc-Huy
    Echelard, Philippe
    LABORATORY INVESTIGATION, 2023, 103 (03) : S92 - S94
  • [30] Directed Therapy of Subtypes of Triple-Negative Breast Cancer
    Carey, Lisa A.
    ONCOLOGIST, 2011, 16 : 71 - 78
12345